Memoral Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT02023346
The purpose of this study is to learn more about the understanding patients with brain tumors have of their disease and their communication with their physician. Ultimately, we hope to use these findings to improve communication between patients and their doctors.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
New York, 10065, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient Inclusion Criteria
Caregiver Inclusion Criteria
Exclusion criteria
Patient Exclusion Criteria
Caregiver Exclusion Criteria
Time frame: 2 years
Prognostic awareness (PA) will be measured using the Chochinov Prognostic Awareness Scale. This scale classifies patients into three categories of awareness: full, limited, or no awareness.
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02303678
Brain Diseases, Brain Neoplasms
Durham, North Carolina, United States
View Trial DetailsNCT04817254
Astrocytoma, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02986178
Astrocytoma, Brain Diseases
San Francisco, California, United States
View Trial DetailsNCT02507583
Brain Diseases, Brain Neoplasms
Philadelphia, Pennsylvania, United States
View Trial Details